$VIR GlaxoSmithKline (GSK) – The drugmaker’s U.S.-listed shares jumped 3.1% in the premarket following a Bloomberg report that the company’s $54 billion consumer products unit is attracting buyout interest from private-equity firms. Glaxo would only say it is “far advanced” with plans to separate the consumer business
1
2
2 Likes